About GenMark Diagnostics
GenMark Diagnostics is a company based in San Diego (United States) founded in 1993 was acquired by Roche in March 2021.. GenMark Diagnostics has raised $8.56 million across 2 funding rounds from investors including Roche and SLR Investment Corp. The company has 797 employees as of December 31, 2021. GenMark Diagnostics offers products and services including ePlex System and ePlex Cartridge. GenMark Diagnostics operates in a competitive market with competitors including Inflammatix, Visby Medical, MeMed, Molbio Diagnostics and Stilla Technologies, among others.
- Headquarter San Diego, United States
- Employees 797 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Roche Diagnostics, North America
-
Annual Revenue
$171.55 M95as on Dec 31, 2020
-
Net Profit
$-18.64 M61as on Dec 31, 2020
-
EBITDA
$-11.05 M74as on Dec 31, 2020
-
Total Equity Funding
$8.56 M (USD)
in 2 rounds
-
Latest Funding Round
$65 M (USD), Debt – Conventional
Feb 08, 2019
-
Investors
Roche
& 1 more
-
Employee Count
797
as on Dec 31, 2021
-
Acquired by
Roche
(Mar 15, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenMark Diagnostics
GenMark Diagnostics offers a comprehensive portfolio of products and services, including ePlex System and ePlex Cartridge. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates nucleic acid testing for pathogen detection.
Enables single-use molecular assays for diagnostics.
Unlock access to complete
Software Development Team
35 people
Product Management Team
21 people
Senior Team
11 people
Leadership Team
9 people
Sales and Marketing
5 people
Scientist Team
5 people
Data Analysis and Operations Team
5 people
Research Team
5 people
Unlock access to complete
Funding Insights of GenMark Diagnostics
GenMark Diagnostics has successfully raised a total of $8.56M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $65 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $65.0M
-
First Round
First Round
(21 Dec 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Debt – Conventional - GenMark Diagnostics | Valuation |
investors |
|
| Dec, 2009 | Amount | Series A - GenMark Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenMark Diagnostics
GenMark Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche and SLR Investment Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Debt and equity investments are offered by the firm.
|
Founded Year | Domain | Location | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenMark Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GenMark Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genmark Diagnostics Comparisons
Competitors of GenMark Diagnostics
GenMark Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Visby Medical, MeMed, Molbio Diagnostics and Stilla Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Digital PCR solutions for research are developed and analyzed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genmark Diagnostics
Frequently Asked Questions about GenMark Diagnostics
When was GenMark Diagnostics founded?
GenMark Diagnostics was founded in 1993 and raised its 1st funding round 16 years after it was founded.
Where is GenMark Diagnostics located?
GenMark Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is GenMark Diagnostics a funded company?
GenMark Diagnostics is a funded company, having raised a total of $8.56M across 2 funding rounds to date. The company's 1st funding round was a Series A of $8.56M, raised on Dec 21, 2009.
How many employees does GenMark Diagnostics have?
As of Dec 31, 2021, the latest employee count at GenMark Diagnostics is 797.
What is the annual revenue of GenMark Diagnostics?
Annual revenue of GenMark Diagnostics is $171.55M as on Dec 31, 2020.
What does GenMark Diagnostics do?
Founded in 1993 in San Diego, United States, multiplexed molecular diagnostics are supported through instruments and test panels. The ePlex System incorporates digital microfluidics for PCR-based assays, with results obtained in under 90 minutes. Disposable cartridges in the XT-8 system enable analyte measurement via electrochemical sensors. Test panels are developed for CNS, GI, respiratory, and hepatic infections, along with genetic disorders.
Who are the top competitors of GenMark Diagnostics?
GenMark Diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does GenMark Diagnostics offer?
GenMark Diagnostics offers ePlex System and ePlex Cartridge.
Who are GenMark Diagnostics's investors?
GenMark Diagnostics has 2 investors. Key investors include Roche, and SLR Investment Corp.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.